Terminated PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT01590342

Diclofenac for Submassive PE (AINEP-1)

Efficacy of Diclofenac for Patients With Acute Submassive Pulmonary Embolism: a Randomized Clinical Trial

Sponsor: Ministry of Health, Spain

Updated 6 times since 2017 Last updated: Sep 5, 2017 Started: May 31, 2012 Primary completion: Jan 31, 2017 Completion: Jun 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Low recruitment rate

Other Pulmonary Embolism trials with similar outcome

Browse all Pulmonary Embolism trials

This PHASE2/PHASE3 trial investigates Pulmonary Embolism and is currently terminated or withdrawn. Ministry of Health, Spain leads this study, which shows 6 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2_PHASE3
Oct 2017 — Jun 2018 [monthly]

Terminated PHASE2_PHASE3

▶ Show 1 earlier version

Jan 2017 — Oct 2017 [monthly]

Terminated PHASE2_PHASE3

First recorded

May 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ministry of Health, Spain

Data source: Ministry of Health, Spain

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Madrid, Spain